UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Whitney Pope, MD, PhD

Print
Email

Whitney Pope, MD, PhD

UCLA Physician Whitney Pope, MD, PhD specializes in Diagnostic Radiology.
Specialty
Diagnostic Radiology
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
A72115
Contact
(310) 267-9783 Office
Fax Number
(310) 825-2776
Email Address
wpope@mednet.ucla.edu
Voted Super Doctor
PRACTICE LOCATION

757 Westwood Plaza, Room 1621E
Los Angeles, CA 90095

MEDICAL BOARD CERTIFICATION
Neuroradiology, American Board of Radiology, 2008
Diagnostic Radiology, American Board of Radiology, 2003, 2013
EDUCATION
Fellowship
Neuroradiology, UCLA School of Medicine, 2003 - 2004
Residency
Radiology, UCLA School of Medicine, 1999 - 2003
Internship
Internal Medicine, VA Greater Los Angeles Healthcare System, 1998 - 1999
Degree
MD, University of Illinois College of Medicine at Chicago, 1998
AFFILIATION
Department Affiliation
Provider, Radiology, Neuroradiology
IN THE NEWS
MORE INFORMATION
Research Interest
1. Brain tumors, in particular Glioblastoma
2. Physiologic Imaging Biomarkers of Treatment Response
3. Genomics and proteomics of Brain Tumor Imaging
4. In vivo detection of IDH1 mutation in brain tumors
5. Standardization of imaging protocols for multicenter drug trials
Additional Information
Academic / Professional Titles
  • Associate Professor of Radiology, Section of Neuroradiology
  • Director, Brain Tumor Imaging
Awards & Recognition
  • Brain Tumor Funders' Collaborative Grant for "New Approaches for Developing Tools for Non-Invasive or Minimally-Invasive Monitoring of Pediatric and Adult Gliomas" 2009-2010
  • Berlex/NER Foundation Fellowship in Basic Science Research Award 2004-05
  • Johnny Mercer Foundation: Brain Tumor Research Award
Publications
Link to PubMed publications »
  1. Tsui HCT, Pope WB, Kim CS, Klein WL, Transient expression of adheron molecules during chick retinal development. J Neurobiol. 1992;23:720-738.
  2. Pope W, Enam SA, Miller BE, Ghanbari HA, Klein WL. Phosphorylated tau isotope of Alzheimer’s disease is coupled to axonal development in the avian central nervous system. Exp Neurol. 1993;120:106-113.
  3. Pope W, Lambert M, Leypold B, Seupaul R, Sletten L, Krafft G, Klein WL. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human Neuroblastoma cell line SH-SY5Y. Exp Neurol. 1994;126:185-194.
  4. Pope W, Sayre J, Perlina A, Villablanca JP, Mischel P, Cloughesy T. Magnetic Resonance Imaging Correlates of Survival in Patients with High Grade Gliomas. Am J Neuroradiol. 2005;26:2466-2474.
  5. Morioka C, El-Saden S, Pope W, Duckwiler G, Bui A, Kangarloo H. Integration of HIS/RIS clinical document with PACS image studies for Neuroradiology. Proc SPIE. 2005;5748:318-325.
  6. Chen W, Cloughesy T, Delaloye S, Czernin J, Kamdar N, Schiepers C, Pope W, Silverman DH. 18FDOPA PET Imaging of Brain Tumors Comparison Study with 18F-FDG PET and Evaluation of Diagnostic Accuracy. J Nucl Med. 2006;47:904-911.
  7. Pope WB, Lai A, Nghiemphu P, Mischel P, Cloughesy TF. MR Imaging in Patients with High Grade Gliomas Treated with Bevacizumab and Chemotherapy. Neurology. 2006;66:1258-1260.
  8. Nael K, Ruehm SG, Michaely H, Pope W, Laub G, Finn JP, Villablanca P. High Spatial-Resolution CE-MRA of the Carotid Circulation with Parallel Imaging: Comparison of image quality between two image quality between two different acceleration factors at 3.0T. Invest Radiology. 2006;41:391-399.
  9. Nael K, Villablanca JP, Saleh R, Pope W, Nael A, Laub G, Finn JP. Contrast-enhanced MR angiography at 3T in the evaluation of intracranial aneurysms: a comparison with time-of-flight MR angiography. Am J Neuroradiol. 2006;27;2118-21.
  10. Nael K, Villablanca P, Pope WB, McNamara T, Laub G, Finn JP. Contrast- enhanced MR Angiography of the Supra-Aortic Arteries at 3.0 Tesla: Highly Accelerated Parallel Acquisition for Improved Spatial Resolution Over an Extended Field of View. Radiology. 2007;242(2):600-609.
  11. *Carlson MJ, *Pope WB, Bronstein J, Lai A, Nghiemphu P, Mischel P, Liau L, Nelson S, Cloughesy TF. Relationship between survival and edema in malignant gliomas: role of VEGF and neuronal pentraxin 2. Clin Cancer Res. 2007;13(9):2592-2598. (*authors contributed equally to this work).
  12. Chen W, Delaloye S, Geist C, Czernin J, Sayre J, Silverman D, Satyamurthy N, Pope W, Lai A, Cloughesy T. Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation with 18F-FLT PET: A Pilot Study. J Clin Oncol. 2007;25:4714-4721.
  13. Nael K, Villablanca JP, Mossaz L, Pope W, Juncosa A, Laub G, Finn JP. 3.0T Contrast-enhanced MR Angiography in Evaluation of Patients with suspected Intracranial Aneurysms: A Comparison with multi-slice CT Angiography. Am J Roentgenol. 2008;190(2):389-95.
  14. Nghiemphu P, Green RM, Pope WB, Lai A, Cloughesy TF. Safety of Anticoagulation Use and Bevacizumab in Patients with Glioma. Neuro Oncol. 2008;10:355-60.
  15. Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T. Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients with Newly-diagnosed Glioblastoma Multiforme: Interim analysis of safety and tolerability. Int J Rad Oncol Biol Phys. 2008;71:1372-80.
  16. Ananthnarayan S, Bahng J, Roring J, Lai A, Nghiemphu P, Cloughesy TF, Pope W. MR imaging findings in GBM patients during prolonged bevacizumab treatment. J Neuroncol. 2008;88(3):339-47.
  17. Morioka C, El-Saden S, Pope W, Sayre J, Duckwiler G, Meng F, Bui A, Kangarloo H. A methodology to integrate clinical data for the efficient assessment of brain-tumor patients. Inform Health Soc Care. 2008:33(1):55-68.
  18. Pope WB, Chen JJ, Dong J, Carlson MR, Perlina A, Cloughesy TF, Liau LM, Mischel PS, Nghiemphu P, Lai A, Nelson SF. Relationship between Gene Expression and Enhancement in Glioblastoma Multiforme: an Exploratory DNA Array Analysis. Radiology. 2008;249:268-277.
  19. Ledezma C, Chen W, Sai V, Freitas B, Czernin J, Cloughesy T, Pope WB. 18F-FDOPA PET/MRI Fusion in Patients with Primary/Recurrent Gliomas: Initial Experience. Eur J Radiology. 2009 Aug;71(2):242-8. Epub 2008 May 29.
  20. Nghiemphu P, Liu W, Lee Y, Than T, Graham C, Lai A, Green RM, Pope WB, Liau LM, Mischel PS, Nelson SF, Elashoff R and Cloughesy TF. Bevacizumab and Chemotherapy for the Treatment of Recurrent Glioblastoma: a Single Institution Experience. Neurology 2009 Apr 7;72(14):1217-22.
  21. Pope W, Kim HJ, Huo J, Alger J, Brown MS, Gjertson D, Sai V, Young JR, Tekchandani L, Cloughesy T, Mischel P, Lai A, Nghiemphu P, Rahmanuddin S and Goldin J. ADC Histogram Analysis Predicts Response to Bevacizumab Treatment in Recurrent GBM. Radiology 2009 Jul;252(1):182-9.
  22. Harley EM, Pope WB, Villablanca JP, Mumford J, Suh R, Mazziotta J, Enzmann D, and Engel S. Recruitment of Face Selective Cortex Across the Acquisition of Radiological Expertise. Cerebral Cortex 2009 Nov;19(11):2746-54. Epub 2009 Mar 25.
  23. Khanlou N, Mathern GW, Mitchell WG, Pope W, Salamon N, Yong WH, Vinters HV. Cortical dysplasia with prominent Rosenthal fiber formation in a case of intractable pediatric epilepsy. Human Path 2009 Aug;40(8):1200-4. Epub 2009 May 8.
  24. Huo J, Okada K, Kim HJ, Pope WB, Goldin JG, Alger JR, Brown MS. CADrx for GBM Brain Tumors: Predicting Treatment Response from Changes in Diffusion-Weighted MRI. Algorithms 2009 2(4):1350-1367.
  25. Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB. Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone. J Neurooncol. 2010 96(3):359-67.
  26. Ringman JM, Pope W and Salamon N. Insensitivity of Clinical MRI Interpretation of Medial Temporal Lobe Atrophy in Familial Alzheimer’s Disease. J Neurol 2010 May; 257(5):839-42.
  27. Pope W, Itagaki M. Characterizing Brain Tumor Research: The Role of the National Institutes of Health. AJNR Am J Neuroradiol 2010 Apr;31(4):605-9.
  28. Pope W, Xia Q, Patton V, Das A, Hambleton J, Kim HJ, Huo J, Brown MS, Goldin J, Cloughesy T. Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab. Neurol 2011;76(5):432-7.
  29. Pope WB, A Lai, R Mehta, HJ Kim, J Qiao, JR Young, X Xue, J Goldin, M Brown, P Nghiemphu, A Tran, T Cloughesy. Apparent diffusion coefficent histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol 2011 May;32(5):882-9.
  30. A Lai, A Tran, PL Nghiemphu, WB Pope, OE Solis, M Selch, E Filka, WH Yong, PS Mischel, LM Liau, S Phuphanich, K Black, S Peak, RM Green, CE Spier, T Kolevska, J Polikoff, L Fehrenbacher, R Elashoff, T Cloughesy. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 2011 Jan 10;29(2):142-8.
  31. Ellingson BM, Coughesy TF, Lai A, Nghiemphu PL, Michel PS, Pope WB. Quantitative volumetric analysis of conventional magnetic resonance imaging response in recurrent glioblastoma treated with bevacizumab. Neuro-onc 2011 Feb 15 [Epub ahead of print].
  32. Ellingson B, KM Schmainda, T Coughesy, PS Michel, A Lai, P Nghiemphu, WB Pope. Graded functional diffusion map (fDM)-defined ADC characteristics predict overall survival in recurrent glioblastoma treated with bevacizumab. Neuro-onc 2011 Aug 19. [Epub ahead of print].
  33. Ellingson B, T Coughesy, A Lai, P Nghiemphu, WB Pope. Cell invasion, motility and proliferation level estimates (CIMPLE) maps derived from serial diffusion MRI in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2011 Mar 26. [Epub ahead of print].
  34. Ellingson B, T Coughesy, A Lai, P Nghiemphu, LM Liau, WB Pope. High order diffusion tensor imaging in human glioblastoma. Acad Rad 2011 Apr 30. [Epub ahead of print].
  35. Lai A*, S Kharbanda*, W Pope*, A Tran, O Solis, K Pujara, J Carillo, A Pandita, F Peale, B Ellingson, CW Bowers, RH Soriano, S Mohan, WH Yong, WF Forest, S Seshagiri, Z Modrusan, K Aldape, P Mischel, L Liau, C Escovedo, W Chen, P Nghiemphu, CD James, M Prados, M Westphal, K Lamzsus, T Coughesy, H Phillips. IDH1 Mutant Glioblastoma: Evidence for Orchestrated Molecular Evolution from a Developmentally Restricted Cell of Origin. J Clin Oncol (in press;*authors contributed equally to this work).
  36. Ellingson B, TF Coughesy, A Lai, P Nghiemphu, WB Pope. Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps (fDMs) in recurrent glioblastoma treated with bevacizumab. Mag Reson Med 2011 Jun 23. [Epub ahead of print].
  37. Ellingson B, TF Coughesy, A Lai, PL Nghiemphu, S Lalezari, T Zaw, K Motevalibashinaeini, PS Michel, WB Pope. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neuro-onc Jun 23.
  38. Pope WB, L Mirsadraei, A Lai, A Eskin, J Qiao, HJ Kim, BM Ellingson, P Nghiemphu, S Kharbanda, R Soriano, S Nelson, W Yong, H Phillips, T Cloughesy. Differential Gene Expression in Glioblastoma Defined by ADC Histogram Analysis: Relationship to Extracellular Matrix Molecules and Survival. AJNR Am J Neurorad (in press).
  39. Schwarzenberg J, Czernin J, Cloughesy T, Ellingson BM, Pope WB, Geist C, Dahlbom M, Silverman DHS, Satyamurthy N, Phelps ME and W Chen. 18F-Fluoro-Thymidine Positron Emission Tomography and MRI for Early Survival Predictions in Patients with Recurrent Malignant Gliomas Treated with Bevacizumab. J Nuc Med (in press).
  40. Ellingson B, TF Cloughesy, WB Pope, TM Zaw, H Phillips, S Lalezari, PL Nghiemphu, H Ibrahim, K Motevalibashinaeini and A Lai. Anatomic localization and of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas. Neuroimage 2012 16;59(2):908-16.
  41. W Pope, RM Prins, A Thomas, WH Yong, H Soto, A Lai, M Bittinger, V Fantin, T Cloughesy, H Kornblum, H Wu, and LM. Liau. Non-invasive detection of 2-hydroxy glutarate in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol 2012 107(1):197-205.
  42. Ellingson B, TM Zaw, T Coughesy, KM Naeini, S Lalezari, Mong S, A Lai, P Nghiemphu, WB Pope. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas. J Magn Reson Imaging 2012 35(6):1472-7.
  43. Carrillo J, Lai A, Nghiemphu PL, Kim HJ, Phillips HS, Kharbanda S, Ellingson BM, Lalaezari S, Yong W, Cloughesy T, Pope WB. Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation and Survival in Glioblastoma. AJNR Am J Neuroradiol 2012 33(7):1349-55.
  44. White CM, Pope WB, Zaw T, Qiao J, Naeini KM, Lai A, Nghiemphu PL, Wang JJ, Cloughesy TF, Ellingson BM. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors. J Neuroimage 2012 Jun 5. doi: 10.1111/j.1552-6569.2012.00703.x.
  45. Ellingson B, TF Coughesy, Zaw T, A Lai, P Nghiemphu, Harris R, Lalezari S, Wagle W, Naeini KM, Carrillo J, Liau LM, WB Pope. Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. Neuro-onc 2012 14(3):333-43.
  46. +Mong S, Ellingson BM, Nghiemphu PL, Kim HJ, Mirsadraei L, Lai A, Yong W, Zaw TM, Liau LM, Cloughesy TF, Pope WB. Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared to Matched Controls. AJNR Am J Neurorad 2012 33(9):1763-70.
  47. Wang DJ, Alger JR, Qiao JX, Hao Q, Hou S, Fiaz R, Gunther M, Pope WB, Saver JL, Salamon N, Liebeskind DS, for the UCLA Stroke Investigators. The Value of Arterial Spin-Labeled Perfusion Imaging in Acute Ischemic Stroke – Comparison with Dynamic Susceptibility Contrast Enhanced MRI. Stroke 2012 43(4):1018-24.
  48. Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Rn PL, Prados M, Goldin J, Wen PY, Cloughesy T. Apparent Diffusion Coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol 2012 108(3):491-8.
  49. Harris RJ, TF Coughesy TF, Pope WB, Nghiemphu PL, Lai A, Zar T, Czernin J, Phelps MR, Chen W, Ellingson BM. 18F-FDOPA and 18F-FLT positron emission tomography parametric response maps (PET PRMs) predict response in recurrent malignant gliomas treated with bevacizumab. Neuro-onc. 2012 14(8):1079-89.
  50. Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL,Vinters HV, Liau LM, Mischel PS, Cloughesy TF. Probabilistic Radiographic Atlas of Glioblastoma Phenotypes. AJNR Am J Neurorad 2013 34(3):533-40.
  51. Lazovic J+, Soto H, Piccioni D, Lo R, Li S, Mirsadraei L, Yong W, Prins R, Liau LM, Ellingson BM, Cloughesy T, Lai A and WB Pope. Detection of 2-hydroxy glutaric acid (2-HG) in-vivo by 1H magnetic resonance spectroscopy in U87 glioma cells overexpressing the isocitrate dehydrogenase 1 (IDH1) mutation. Neuro-onc 2012 14(12):1465-72.
  52. Akhtari M, W Pope, G Mathern, R Moats, A Frew, M Mandelkern. Functionalized magnetonanoparticles in visualization of intracranial tumors on MRI. Mol Imaging Biol 2013 Jun;15(3):299-306.
  53. Naeini K+, WB Pope, TF Cloughesy, RJ Harris, A Lai, A Eskin, R Chowdhury, PL Nghiemphu, Y Behbahabian, BM Ellingson. Identifying the Mesenchymal Molecular Subtype of Glioblastoma Using Quantitative Volumetric Analysis of Anatomic Magnetic Resonance Images. Neuro-onc 2013 May;15(5):626-34.
  54. Qiao XJ+, N Salamon, DJ Wang, R He, M Linetsky, BM Ellingson, WB Pope. Perfusion Deficits Detected by Arterial Spin-Labeling in Patients with TIA with Negative Diffusion and Vascular Imaging. AJNR Am J Neurorad 2013;34(11):2125-30.
  55. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, WB Pope. Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiotherapy. Neuro-onc 2013 Mar;15(3):382-90.
  56. Harris RJ, Cloughesy TF, Pope WB, Godinez S, Yutaka N, Nghiemphu PL, Meyer H, Paul D, Behbahanian Y, Lai L, BE Ellingson. Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma. J Neuro-onc 2013 Apr;112(2):257-66.
  57. Lalezari S, AP Chou, A Tran, OE Solis, N Khanlou, W Chen, S Li, J Carrillo, R Chowdhury, Julia Selfridge, D Sanchez, R Wilson, M Zurayk , J Lalezari, J Lou, L Ormiston, K Ancheta, R Hanna, P Miller, D Piccioni, B Ellingson, C Buchanan, PS Mischel, PL Nghiemphu, R Green, HJ Wang, WB Pope, LM Liau, RM Elashoff, TF Cloughesy, WH Yong, A Lai. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. Neuro-onc 2013 Mar;15(3):370-81.
  58. Huo J, HJ Kim, J Goldin, E van Rikxoort, M Brown, WB Pope, J Alger, K Okado. Ensemble segmentation for GBM brain tumors on MR images using confidence-based averaging. Med Phys 2013 40(9):093502.
  59. Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC, Lai A, Nghiemphu PL, Mason W, Cloughesy TF. Pre-treatment ADC histogram analysis is a predictive, not prognostic, imaging biomarker for recurrent glioblastoma treated with bevacizumab. AJNR Am J Neuroradiol 2014;35:673-9.
  60. BM Ellingson, HJ Kim, DC Woodworth, WB Pope, JN Cloughesy, RJ Harris, A Lai, PL Nghiemphu, TF Cloughesy. Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial. Radiology 2014;271:200-10.
  61. Tran AN, Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC, Nghiemphu PL, Cloughesy TF, Ellingson BM. Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry. Neuro-Onc 2014;16(3):414-20.
  62. Harris R, SY Bookheimer, TF Cloughesy, HJ Kim, WB Pope, A Lai, PL Nghiemphu, LM Liau, BM Ellingson. Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. J Neuro-onc 2014;116(2):373-9.
  63. Wang DJ, Alger JR, Qiao JX, Gunther M, Pope WB, Saver JL, Salamon N, Liebeskind DS, UCLA Stroke Investigators. Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging. Neuroimage (Amst). 2013 Jul 6;3:1-7. doi: 10.1016/j.nicl.2013.06.017.
  64. Avliyakulov NK, Rajavel KS, Le KMT, Guo L, Mirsadraei L, Lee S, Yong WH, Liau LM, Lai A, Nghiemphu PL, Cloughesy TF, Linetsky M, Haykinson MJ, WB Pope. C-terminally truncated form of aB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma. J Neuro-onc 2014;117:53-65.
  65. Woodworth DC, WB Pope, LM Liau, HJ Kim, A Lai, PL Nghiemphu, TF Cloughesy, BM Ellingson. Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma. J Neuro-onc 2014;116(3):551-8.
  66. Zaw, TM, WB Pope, TF Cloughesy, A Lai, PL Nghiemphu, BM Ellingson. Short-interval estimation of proliferation rate using serial diffusion MRI predicts progression-free survival in newly diagnosed glioblastoma treated with radiochemotherapy. J Neuro-onc 014;116:601-08.
  67. Piccioni DE, J Selfridge, RR Mody, R Chowdhury, S Li, S Lalezari, J Wawrzynski, J Quan, M Zurayk, AP Chou, DE Sanchez, LM Liau, BM Ellingson, WB Pope, PL Nghiemphu, RM Green, HJ Wang, WH Yong, R Elashoff, TF Cloughesy, A Lai. Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro-onc 2014 Mar 13. [Epub ahead of print]
  68. Schwarzenberg J, J Czernin, T Cloughesy, BM Ellingson, T Grogan, D Elashoff, WB Pope, C Geist, DH Silverman, ME Phelps, W Chen. Treatment Response Evaluation using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy. Clin Can Res 2014 Mar 31. [Epub ahead of print]
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Whitney Pope, click here to update your profile.